Clinical Trials
2 trialsNCT05247684 2026-03-05
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC
Akeso
Phase 2 Active not recruiting
NCT06161441 2026-01-12
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
Regeneron Pharmaceuticals
Phase 2 Active not recruiting